During the past decade, UNC Hospitals CTRC conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 2 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "UNC Hospitals CTRC" #1 collaborator was "Pfizer" with 1 trials as a collaborator and "Tibotec Pharmaceutical Limited" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "UNC Hospitals CTRC" are "Crohn's Disease" (2 trials), "HIV/AIDS" (2 trials), "HIV Infections" (1 trials) and "Healthy Adult Females" (1 trials). Many other conditions were trialed in "UNC Hospitals CTRC" in a lesser frequency.

Most popular intervention types in "UNC Hospitals CTRC" are "Drug" (4 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Etravirine" (1 trials), "Maraviroc" (1 trials), "PF-00547659" (1 trials), "PF-00547659 SC injection" (1 trials) and "Pharmacokinetic Sampling" (1 trials). Other intervention names were less common.

The vast majority of trials in "UNC Hospitals CTRC" are 2 trials for "All" genders, 2 trials for "Male" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "UNC Hospitals CTRC". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in UNC Hospitals CTRC, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in UNC Hospitals CTRC, 3 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".